Apparently, the ability of the synthesized inhibitors to affect the proliferation of cancer cells is not only mediated through their MAO-A inhibition but also crosslinks with several signaling pathways in the cancer cell, suggesting new roles of MAO-A at the molecular level. Here, MAOA is linked to cancer.